Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
HCRN GU14-182
Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
- NCT02500121 ↗
- Completed
- Matthew Galsky
- Focused
We haven't built an HCP commentary report on HCRN GU14-182 (pembrolizumab in metastatic urothelial cancer after first-line chemotherapy) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on HCRN GU14-182 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 6 |
The trial
ClinicalTrials.gov- Official title
- A Randomized, Double-blinded, Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer: Hoosier Cancer Research Network GU14-182
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Urothelial Carcinoma; Bladder Cancer
- Interventions
- Placebo; Pembrolizumab
- Arms
- Control Arm A · Placebo comparator
- Experimental Arm B · Experimental
- Enrollment
- 108
- Primary outcomes
- Progression-free Survival (PFS)
- Sponsor
- Matthew Galsky with Hoosier Cancer Research Network, Merck Sharp & Dohme LLC
- Start
- Nov 11, 2015
- Primary completion
- Jul 1, 2019
- Results posted
- Yes
- Registry record
- NCT02500121 · updated Sep 30, 2022
Publications
linked from the registry- Galsky MD, Mortazavi A, Milowsky MI, George S, Gupta S, Fleming MT, Dang LH, Geynisman DM, Walling R, Alter RS, Kassar M, Wang J, Gupta S, Davis N, Picus J, Philips G, Quinn DI, Haines GK 3rd, Hahn NM, Zhao Q, Yu M, Pal SK. Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer. J Clin Oncol. 2020 Jun 1;38(16):1797-1806. doi: 10.1200/JCO.19.03091. Epub 2020 Apr 9. PubMed 32271672